OHSU in the news

Golimumab gets FDA nod for two new indications

Medscape November 03, 2017
In response to the FDA approval of a new drug for adults with active psoriatic arthritis or active ankylosing spondylitism, Dr. Atul Deodhar says: “Ankylosing spondylitis is a disease that adversely affects quality of life and the choices for treating this disabling condition are limited. The approval of IV golimumab for the treatment of active ankylosing spondylitis provides a welcomed new option.”

Philanthropy from the heart

Lake Oswego Review November 02, 2017
Jim Rudd’s roles on the OHSU steering committee and the Knight Cancer Council are mentioned in an in-depth profile on Rudd family philanthropy.

Study: Common procedure for heart-related chest pain doesn't work

The Oregonian November 02, 2017
In response to a study that found a common heart procedure to relieve chest pain doesn’t work, Dr. Vinay Prasad says: “The real lesson here is that costly invasive procedures performed on patients should be tested prior to their use and not two decades later.”

Dad’s nutrition affects baby, too

The Bulletin November 02, 2017
Dr. Kent Thornburg says: “Diets for adolescent boys and young men are really important and we should be telling them, as we have been telling girls, that their lifestyle and their diets will make a difference in the health of their offspring.”

ACC: Even very low dose Rivaroxaban prevents recurrent VTE

MedPage Today November 01, 2017
In response to a study that found continuing use of rivaroxaban appears to reduce the risk of recurrent venous thromboembolism without increasing the risk for bleeding, Dr. Sandra Lewis says: “Clotting and bleeding have been the focus of so many studies over the years, but those studies are usually focused in the coronary bed, so I am really glad to see these data."
See more stories